Acute pancreatitis (AP) is diagnosed when at least two of the following criteria are met: abdominal pain characteristic of the disease, serum lipase or amylase levels greater than three times the upper limit of normal, and findings consistent with AP on imaging. Serum lipase is the preferred diagnostic marker due to its superior sensitivity and specificity. Routine CT imaging at admission is not recommended unless the diagnosis is unclear or the patient fails to improve clinically within 48–72 hours. Imaging, including contrast-enhanced CT or MRI, is reserved for evaluating complications such as necrosis or pseudocysts in patients with persistent or worsening symptoms. Identifying the etiology of AP is essential for effective management. For biliary pancreatitis, transabdominal ultrasound is the first-line imaging modality, with repeat studies recommended if the initial results are inconclusive. For idiopathic AP (IAP), additional evaluation with MRI or endoscopic ultrasound (EUS) is suggested. In patients without gallstones or a history of significant alcohol use, serum triglycerides should be measured, and levels exceeding 1,000 mg/dL suggest hypertriglyceridemia as the cause. For patients over 40 years of age with no established etiology, pancreatic cancer should be considered and further evaluated.
Initial management of AP focuses on supportive care. Fluid resuscitation with lactated Ringer’s solution is recommended, with frequent reassessments to avoid volume overload, especially in patients with cardiovascular or renal comorbidities. Nutrition should be initiated early, preferably within 24–48 hours, with a low-fat solid diet in mild cases. In severe cases, enteral nutrition is preferred over parenteral nutrition, with nasogastric feeding being the optimal route due to its comparable safety and efficacy. Interventions should be tailored to clinical need. Antibiotics are not indicated for sterile necrosis but should be used in cases of infected necrosis to delay or potentially avoid invasive drainage. Endoscopic retrograde cholangiopancreatography (ERCP) is indicated within 24 hours for AP complicated by cholangitis but should not be routinely performed for biliary AP without cholangitis. Prevention of post-ERCP pancreatitis includes rectal indomethacin and, in high-risk cases, pancreatic duct stenting. To reduce recurrence risk, patients with idiopathic AP should undergo a cholecystectomy after a second episode if they are fit for surgery. Overall, these guidelines emphasize the importance of a stepwise diagnostic and therapeutic approach to manage AP effectively and minimize complications.
Q1. What criteria are used to diagnose acute pancreatitis (AP)?
Q2. Which is the preferred marker for diagnosing AP: serum amylase or lipase?
Q3. Does elevated amylase or lipase alone confirm the diagnosis of AP?
Q4. Should routine CT imaging be performed early or at admission for AP?
Q5. When is imaging indicated in AP?
Q6. What imaging modalities are recommended to evaluate complications in AP?
Q7. What initial imaging should be performed to evaluate for biliary pancreatitis?
Q8. What test is recommended if gallstones and alcohol use are absent?
Q9. What evaluation is necessary for patients over 40 years old or those with idiopathic AP?
Q10. What steps should be taken if the etiology of AP remains unclear?
Q11. What type of fluid is preferred for resuscitation in AP?
Q12. How should fluid resuscitation be monitored in AP?
Q13. When should oral feeding be initiated in mild AP?
Q14. What type of diet should be started in AP?
Q15. Should prophylactic antibiotics be given in sterile pancreatic necrosis?
Q16. Is fine-needle aspiration (FNA) recommended in suspected infected necrosis?
Q17. When is ERCP indicated in AP?
Q18. Should routine early ERCP be used in biliary AP without cholangitis?
Q19. Are antibiotics indicated in severe AP with sterile necrosis?
Q20. What is the preferred route for nutrition in AP?
Q21. When should nasogastric feeding be used in severe AP?
Q22. How can post-ERCP pancreatitis be prevented in high-risk patients?
Q23. What parameters should be monitored in AP?
Q24. What is the recommended clinical approach during the initial 48 hours for mild AP?
Q1. Should routine CT imaging be performed early or at admission for acute pancreatitis (AP)?
Q2. What tests should be performed in the absence of gallstones or a history of alcohol use to determine the etiology of AP?
Q3. What additional evaluation is recommended for patients older than 40 years with idiopathic AP?
Q4. What surgical intervention is suggested for patients after a second episode of idiopathic AP?
Q5. How should patients with AP be stratified for admission settings?
Q6. Where should patients with organ failure or systemic inflammatory response syndrome (SIRS) be admitted?
Q7. Are scoring systems or imaging effective in predicting the development of severe AP?
Q8. What is the recommended clinical approach for patients with mild AP?
Q9. What are key risk factors for the development of severe AP?
Q10. What fluid resuscitation strategy is recommended for AP patients, and what precautions should be taken?
Q11. When is fluid resuscitation most critical in AP management?
Q12. How often should fluid volume and response be reassessed in AP patients?
Q13. When is early ERCP indicated for AP?
Q14. Should diagnostic ERCP be used routinely for common bile duct stones in AP?
Q15. Are antibiotics recommended for sterile pancreatic necrosis in AP?
Q16. How should infected pancreatic necrosis be managed?
Q17. Are antifungal agents recommended alongside antibiotics in AP?
Q18. What type of nutrition is recommended for patients with moderately severe or severe AP?
Q19. When should parenteral nutrition be used in AP?
Q20. Which route of enteral feeding is preferred in AP?
Q21. When should patients with mild acute biliary pancreatitis undergo cholecystectomy?
Q22. What type of intervention is preferred for symptomatic pancreatic necrosis in stable patients?
Q23. When should interventions for pancreatic necrosis be delayed?
Q1. What imaging modality is recommended to evaluate for biliary pancreatitis in acute pancreatitis (AP)?
Q2. What diagnostic steps are suggested for idiopathic acute pancreatitis (IAP)?
Q3. When should serum triglycerides (TG) be measured in AP, and what threshold indicates it as the etiology?
Q4. What evaluation is recommended for patients older than 40 years with AP of unknown etiology?
Q5. What surgical intervention is suggested after a second episode of AP with no identifiable cause?